The Division of Molecular and Cellular Biosciences (MCB) joins the National Science Foundation (NSF), and the scientific community in congratulating Dr. Jennifer Doudna and Dr. Emmanuelle Charpentier on their 2020 Nobel Prize in Chemistry. The two were awarded the prize jointly “for the development of a method for genome editing.” A little over a decade ago, MCB awarded Dr. Doudna the first in a series of grants to explore Mechanisms of Acquired Immunity in Bacteria (MCB 1244557). “It is wonderful to see the fruits of Dr. Doudna’s work, initially enabled by NSF investment in discovery-driven research, which is reaping many societal benefits” said Dr. Basil Nikolau, MCB Division Director.
“CRISPR-Cas9 is opening new worlds of possibility in fields as wide-ranging as bioengineering, medicine, agriculture, and biomanufacturing. Researchers are still working to understand the full potential of this important tool,” said National Science Foundation Director Sethuraman Panchanathan. “The teams behind this groundbreaking discovery have uncovered and developed fundamental science that will result in decades’ worth of applications. NSF has long supported the discovery-driven research of Dr. Jennifer Doudna and her lab with grants, including our prestigious Alan T. Waterman award. We congratulate her and Emmanuelle Charpentier and join the rest of the world in waiting to see what CRISPR produces next,” said Dr. Panchanathan in a news release.